Company

Built by the people who made editing industrial.

Twenty-five years of genome engineering — the technologies that made programmable editing a process you can run at scale and on a schedule.

Ryan T. Gill
Ryan T. Gill
Co-Founder, CEO & Director
Inscripta · Artisan · SynBio pioneer
LinkedIn
Tanya Warnecke-Gill
Tanya Warnecke-Gill
Co-Founder, CTO & Director
Inscripta CTO · Artisan CTO · 35+ patents
LinkedIn
Ryan Layer
Ryan Layer
Co-Founder & CSO
CU Boulder · BioFrontiers · Variant AI
LinkedIn

Board of Directors

Sandy Zweifach
Sandy Zweifach
Chairman
LinkedIn
Dalton Wright
Dalton Wright
Director
Kickstart Ventures
LinkedIn
Mark Lupa
Mark Lupa
Director
Buff Gold Ventures
LinkedIn
Ryan T. Gill
Director
Co-Founder & CEO
Tanya Warnecke-Gill
Director
Co-Founder & CTO

Scientific & Industry Advisors

Chris Voigt
Chris Voigt
Chairman, SAB
MIT
Alisa Gaskell
Alisa Gaskell
Chief Genomics Officer
Children's Hospital Colorado
Matt Childs
Matt Childs
Professor, Genomics
Imperial College London
George Church
George Church
Professor, Genetics
Harvard
Greg Findlay
Greg Findlay
Professor, Genomics
The Francis Crick Institute
Aaron Quinlan
Aaron Quinlan
Professor, Genetics
University of Utah
Dieter Weinand
Dieter Weinand
CEO (former)
Bayer HealthCare
Stefan Wildt
Stefan Wildt
CTO (former)
Takeda

Backed by

Kickstart Ventures
Buff Gold Ventures
Denver Ventures
Service Provider Capital
Collaborate

Which variants would you test if you could?

A GWAS never functionally resolved. A platform that needs a causal layer. A model that needs ground truth.

Your privacy choices

We would like your consent before any analytics or marketing technology is loaded on this site. Nothing in those categories loads unless you allow it. Strictly necessary storage — used only to remember this choice — is always on. See our Privacy Policy.